Tenders

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredients Mentioned with the Possibility of Conclusion as Part of the So-Called Open House Procedure.

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Cariprazine (Atc Code: N05ax15).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Drugs with the Active Ingredient Febuxostat (Atc Code: M04aa03).

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Medicines with the Active Ingredient Rasagiline (Atc Code: N04bd02).

Open House Original Discount Agreements 2024-08 - Fluticasone/Vilanterol (Combination of Active Ingredients)

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V with the Active Ingredient Chlorthalidone in the Dosage Form Tab

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Testosterone Enanthate + Undecanoate in the Dosage Form Ilo

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Codeine in the Dosage Form Tei

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Dimethyl Fumarate

Open House Contracts 2024-3